Richard Nolan Townsend, Chief Executive Officer at Lexeo Therapeutics, Inc. (LXEO), sold 5,000 shares at $8.10 ($41K) on 2024-10-10, disclosed to the SEC on 2024-10-15.
Scheduled sale ($40k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| LXEO | SELL | 2026-05-20 | $17K | — | Filing → |
| LXEO | SELL | 2026-04-07 | $313K | — | Filing → |
| LXEO | SELL | 2026-02-20 | $65K | — | Filing → |